Table 1.
Clinical and biological data from patients with pulmonary mucormycosis.
| Patient | Underlying | Location of | Sputum | 1, 3-beta- | Galacto | CT finding | Pulmonary | Broncho | Cyto | Lavage |
|---|---|---|---|---|---|---|---|---|---|---|
| No. | disease | Pulmonary | culture | D-glucan | mannan | diseasea | fibroscopy | frequency | Sample | |
| infection | assay | assay | ||||||||
| 1 | LC | SR | ND | ND | ND | ND | TB | Luminal stenosis | 1 | NO |
| 2 | LC | IR | ND | ND | ND | Mass | LC | Normal | 1 | NO |
| 3 | Bronchiectasis, diabetes | IR | Negative | Negative | ND | Cavitation | Mycosis | Luminal stenosis | 2 | NO |
| 4 | LC | SL | Negative | ND | ND | Consolidation | Pulmonary infectionb | Purulent secretion | 1 | NO |
| 5 | CKD, diabetes | SR | Negative | Negative | ND | Cavitation | Pulmonary infection | Luminal stenosis | 1 | NO |
| 6 | Diabetes | SR | Rhizomucor sp | Negative | Negative | Cavitation | Pulmonary infection | Normal | 1 | Negative |
| 7 | Diabetes | IL | Negative | Negative | Negative | Mass | Pulmonary abscess | Necrosis | 1 | NO |
| 8 | CKD, diabetes | SR | Negative | Negative | Negative | Nodule, pleural effusion | Pulmonary infection | Luminal stenosis | 1 | NO |
| 9 | Diabetes | SR | Negative | Negative | Negative | Nodule, Cavitation | TB | Necrosis | 1 | NO |
| 10 | LC | MR | Negative | Negative | Negative | Cavitation | Mycosis | Normal | 1 | NO |
| 11 | Diabetes | IR | Negative | Negative | Negative | Consolidation | TB | Necrosis | 1 | NO |
| 12 | Diabetes | IL | Negative | Negative | Negative | Nodule | Mycosis | Necrosis | 1 | NO |
| 13 | Diabetes | SL | Negative | Negative | Negative | Mass, Cavitation | Pulmonary infection | Necrosis | 1 | NO |
| 14 | COPD | IR | Negative | Negative | Negative | Mass | Pulmonary infection | Luminal stenosis | 2 | Negative |
| 15 | COPD | SR | Rhizopus sp | Positive | Positive | Cavitation | Mycosis | Normal | 3 | Negative |
| 16 | Diabetes | SR | Negative | Negative | Negative | Cavitation | Pulmonary infection | Necrosis | 1 | Negative |
| 17 | LC | SL | ND | ND | ND | Nodule | LC | Normal | 1 | NO |
| 18 | CKD, diabetes | SR | Negative | ND | Positive | Cavitation | Pulmonary infection | Luminal stenosis | 1 | NO |
| 19 | COPD, Diabetes | IR | Negative | Negative | Positive | Mass | Pulmonary infection | Necrosis | 1 | NO |
| 20 | ALL, diabetes | SR | ND | ND | ND | Mass | Pulmonary infection | hemorrhage | 1 | NO |
| Renal transplant | ||||||||||
| 21 | LC | IR | ND | ND | ND | Nodule | LC | Purulent secretion | 1 | NO |
| 22 | CKD, diabetes | SL | Negative | Negative | Negative | Nodule, Cavitation | LC | Normal | 1 | NO |
| 23 | Diabetes | IL | Lichtheimia corymbifera | Positive | Positive | Nodule | Pulmonary infection | Purulent secretion | 1 | NO |
| 24 | Diabetes | IL | Lichtheimia corymbifera | Positive | Positive | Nodule | Pulmonary infection | Neoplasm | 2 | Negative |
| 25 | Diabetes | MR | Negative | Negative | Positive | Cavitation | Pulmonary infection | Normal | 1 | NO |
| 26 | Diabetes | SR | Negative | ND | Positive | Nodule, Cavitation | Mycosis | Necrosis | 2 | NO |
| 27 | AML | IR | Negative | Negative | Positive | Consolidation | Pulmonary infection | Normal | 1 | Mucormycosis |
LC, lung cancer; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; ALL, acute lymphoblastic leukemia; AML, acute myeloblastic leukemia; SL, superior lobe of left lung; IL, inferior lobe of left lung; SR, superior lobe of right lung; MR, middle lobe of right lung; IR, inferior lobe of right lung; ND, not done; NA, not available; TB, tuberculosis; apulmonary disease suspected by the clinician before fiberoptic bronchoscopy; bpulmonary infection, not exclude fungal infections.